Literature DB >> 21057983

The "dying-back" phenomenon of motor neurons in ALS.

Michal Dadon-Nachum1, Eldad Melamed, Daniel Offen.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a lethal disease, characterized by progressive death of motor neurons with unknown etiology. Evidence from animal models indicates that neuronal dysfunction precedes the clinical phase of the disease. However, in parallel extensive nerve sprouting and synaptic remodeling as part of a compensatory reinnervation processes and possibly also of motor neurons pathology was demonstrated. Therefore, the weakness in muscle groups will not be clinically apparent until a large proportion of motor units are lost. This motor unit loss and associated muscle function which precedes the death of motor neurons may resemble the "die-back" phenomena. Studies indicated that in the early stages the nerve terminals and motor neuron junctions are partially degraded while the cell bodies in the spinal cord are mostly intact. Treatments to rescue motor neurons according to "dying-forward" model of motor neuron pathology in ALS have shown only limited success in SOD1(G93A) transgenic mice as well as in humans. If cell body degeneration is late compared with axonal degeneration, early intervention could potentially prevent loss of motor neurons. Therefore, it should be considered, according to the dying back hypothesis, to focus on motor neurons terminals in order to delay or prevent the progressive degradation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21057983     DOI: 10.1007/s12031-010-9467-1

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  54 in total

Review 1.  The bound leading the bound: target-derived receptors act as guidance cues.

Authors:  Steven A Crone; Kuo-Fen Lee
Journal:  Neuron       Date:  2002-10-24       Impact factor: 17.173

2.  A longitudinal study comparing thenar motor unit number estimates to other quantitative tests in patients with amyotrophic lateral sclerosis.

Authors:  K J Felice
Journal:  Muscle Nerve       Date:  1997-02       Impact factor: 3.217

3.  IGF-I specifically enhances axon outgrowth of corticospinal motor neurons.

Authors:  P Hande Ozdinler; Jeffrey D Macklis
Journal:  Nat Neurosci       Date:  2006-10-22       Impact factor: 24.884

4.  Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases.

Authors:  D Frey; C Schneider; L Xu; J Borg; W Spooren; P Caroni
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

Review 5.  Molecular and cellular pathways of neurodegeneration in motor neurone disease.

Authors:  P J Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

6.  BDNF heightens the sensitivity of motor neurons to excitotoxic insults through activation of TrkB.

Authors:  Peter Hu; Robert G Kalb
Journal:  J Neurochem       Date:  2003-03       Impact factor: 5.372

7.  Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1(G93A) ALS mouse model.

Authors:  C R Hayworth; F Gonzalez-Lima
Journal:  Neuroscience       Date:  2009-08-20       Impact factor: 3.590

8.  Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.

Authors:  J D Rothstein; L Jin; M Dykes-Hoberg; R W Kuncl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

Review 9.  Semaphorin function in neural plasticity and disease.

Authors:  R Jeroen Pasterkamp; Roman J Giger
Journal:  Curr Opin Neurobiol       Date:  2009-06-21       Impact factor: 6.627

10.  VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.

Authors:  Mimoun Azzouz; G Scott Ralph; Erik Storkebaum; Lucy E Walmsley; Kyriacos A Mitrophanous; Susan M Kingsman; Peter Carmeliet; Nicholas D Mazarakis
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

View more
  147 in total

1.  Retinoid receptors trigger neuritogenesis in retinal degenerations.

Authors:  Yanhua Lin; Bryan W Jones; Aihua Liu; James F Tucker; Kevin Rapp; Ling Luo; Wolfgang Baehr; Paul S Bernstein; Carl B Watt; Jia-Hui Yang; Marguerite V Shaw; Robert E Marc
Journal:  FASEB J       Date:  2011-09-22       Impact factor: 5.191

2.  The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth.

Authors:  Claudia Fallini; Gary J Bassell; Wilfried Rossoll
Journal:  Hum Mol Genet       Date:  2012-05-28       Impact factor: 6.150

Review 3.  Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases.

Authors:  Junying Yuan; Palak Amin; Dimitry Ofengeim
Journal:  Nat Rev Neurosci       Date:  2019-01       Impact factor: 34.870

4.  ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression.

Authors:  Yajuan Xiao; Chehade Karam; Jianxun Yi; Lin Zhang; Xuejun Li; Dosuk Yoon; Huan Wang; Kamal Dhakal; Paul Ramlow; Tian Yu; Zhaohui Mo; Jianjie Ma; Jingsong Zhou
Journal:  Pharmacol Res       Date:  2018-09-18       Impact factor: 7.658

5.  Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α.

Authors:  Wenjun Song; Yuting Song; Brad Kincaid; Blaise Bossy; Ella Bossy-Wetzel
Journal:  Neurobiol Dis       Date:  2012-07-20       Impact factor: 5.996

6.  Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models.

Authors:  Louise Hedskog; Catarina Moreira Pinho; Riccardo Filadi; Annica Rönnbäck; Laura Hertwig; Birgitta Wiehager; Pia Larssen; Sandra Gellhaar; Anna Sandebring; Marie Westerlund; Caroline Graff; Bengt Winblad; Dagmar Galter; Homira Behbahani; Paola Pizzo; Elzbieta Glaser; Maria Ankarcrona
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-25       Impact factor: 11.205

7.  Measuring Neuromuscular Junction Functionality.

Authors:  Emanuele Rizzuto; Simona Pisu; Carmine Nicoletti; Zaccaria Del Prete; Antonio Musarò
Journal:  J Vis Exp       Date:  2017-08-06       Impact factor: 1.355

8.  Wnt and extraocular muscle sparing in amyotrophic lateral sclerosis.

Authors:  Linda K McLoon; Vahid M Harandi; Thomas Brännström; Peter M Andersen; Jing-Xia Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-14       Impact factor: 4.799

9.  Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9.

Authors:  Barbara Commisso; Lingjun Ding; Karl Varadi; Martin Gorges; David Bayer; Tobias M Boeckers; Albert C Ludolph; Jan Kassubek; Oliver J Müller; Francesco Roselli
Journal:  Elife       Date:  2018-08-23       Impact factor: 8.140

10.  Characterization of intercostal muscle pathology in canine degenerative myelopathy: a disease model for amyotrophic lateral sclerosis.

Authors:  Brandie R Morgan; Joan R Coates; Gayle C Johnson; Alyssa C Bujnak; Martin L Katz
Journal:  J Neurosci Res       Date:  2013-09-16       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.